Rise of scientific excellence and collaboration for implementing personalised me...
Rise of scientific excellence and collaboration for implementing personalised medicine in Estonia
Emerging personalised medicine initiatives have the perspective to cut healthcare costs and improve the overall health of the population. Taking into account the individual’s molecular characteristics complemented by environmental...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
DCPM
Digitalized Clone for Personalized Medicine
865K€
Cerrado
EHR4CR
Electronic Health Record systems for Clinical Research
17M€
Cerrado
EHR4CR
Electronic Health Record systems for Clinical Research
17M€
Cerrado
PDC2021-121243-I00
PLATAFORMA DELFOS: SISTEMA DE INFORMACION PARA LA GESTION DE...
102K€
Cerrado
U-PGx
Ubiquitous Pharmacogenomics U PGx Making actionable pharm...
15M€
Cerrado
PreMeDosE
Precision Medicine via Diagnostic Enzyme Activity Testing
150K€
Cerrado
Información proyecto ePerMed
Duración del proyecto: 38 meses
Fecha Inicio: 2015-12-14
Fecha Fin: 2019-02-28
Líder del proyecto
TARTU ULIKOOL
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
1,000K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Emerging personalised medicine initiatives have the perspective to cut healthcare costs and improve the overall health of the population. Taking into account the individual’s molecular characteristics complemented by environmental and lifestyle factors, will allow to develop more precise and improved disease prevention and treatment programs compared to conventional methods. As an example of potential for personalised medicine, an estimated 90% of drugs are effective in only 30-50% of the population, which means that more than a third of all money spent on drugs has been ineffective.
Research opportunities provided by the unique sources of EGC-UT Biobank, nation-wide Electronic Medical Records systems and the Estonian National Personal Medicine Pilot project can be effectively translated into improved understanding of disease etiopathologies and clinical benefit through early diagnosis, risk stratification, treatment and management. The ePerMed project is aimed at increasing the scientific excellence of EGC-UT in the fields of functional and statistical genomics of common and rare diseases by capitalizing on knowledge transfer from two internationally renowned partners in the field of human and medical genomics – UNIL-CIG in Switzerland and UH-FIMM in Finland.
As a foreseen result of the ePerMed project, EGC-UT will have the capacity to move from the current research on the genome-wide association studies to advanced research of disease mechanisms and to clinical benefits through early diagnosis, reliable risk stratification and improved treatment strategies. Ultimately, this will enable EGC-UT to deliver effective personalised medicine across several clinically relevant phenotypic traits and diseases.